Your browser doesn't support javascript.
loading
Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study.
Trotman, Judith; Presgrave, Peter; Carradice, Duncan P; Lenton, Douglas Stuart; Gandhi, Maher K; Cochrane, Tara; Badoux, Xavier; Carlson, Julia; Nkhoma, Gloria; Butcher, Belinda; Nikpour, Armin; Fulham, Michael; Johnston, Anna M.
Afiliación
  • Trotman J; Haematology, Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.
  • Presgrave P; University of Sydney, Camperdown, NSW, Australia.
  • Carradice DP; Department of Haematology, Wollongong Hospital, NSW, Australia.
  • Lenton DS; Department of Haematology and Medical Oncology, Western Health and University of Melbourne, St Albans, VIC, Australia.
  • Gandhi MK; Orange Hospital, NSW, Australia.
  • Cochrane T; University of Sydney, Orange, NSW, Australia.
  • Badoux X; Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Carlson J; Mater Research University of Queensland, Brisbane, QLD, Australia.
  • Nkhoma G; Department of Haematology, Gold Coast University Hospital, Southport, Australia.
  • Butcher B; Griffith University, Southport, Australia.
  • Nikpour A; University of New South Wales, Sydney, NSW, Australia.
  • Fulham M; Australasian Leukaemia and Lymphoma Group, Richmond, VIC, Australia.
  • Johnston AM; Australasian Leukaemia and Lymphoma Group, Richmond, VIC, Australia.
Hemasphere ; 7(3): e836, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36844180

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Hemasphere Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Hemasphere Año: 2023 Tipo del documento: Article